BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 36122544)

  • 1. Immunometabolic alterations in lupus: where do they come from and where do we go from there?
    Ma L; Roach T; Morel L
    Curr Opin Immunol; 2022 Oct; 78():102245. PubMed ID: 36122544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunometabolism and systemic lupus erythematosus].
    Xiao YB; Guo MY; Zuo XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1120-1124. PubMed ID: 30562794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Intersection of Cellular and Systemic Metabolism: Metabolic Syndrome in Systemic Lupus Erythematosus.
    Terrell M; Morel L
    Endocrinology; 2022 Jul; 163(7):. PubMed ID: 35560001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunometabolism in systemic lupus erythematosus.
    Morel L
    Nat Rev Rheumatol; 2017 May; 13(5):280-290. PubMed ID: 28360423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunometabolism in systemic lupus erythematosus: Relevant pathogenetic mechanisms and potential clinical applications.
    Tzeng HT; Chyuan IT
    J Formos Med Assoc; 2021 Sep; 120(9):1667-1675. PubMed ID: 33836940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal Mitochondrial Physiology in the Pathogenesis of Systemic Lupus Erythematosus.
    Wincup C; Radziszewska A
    Rheum Dis Clin North Am; 2021 Aug; 47(3):427-439. PubMed ID: 34215372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cellular overview of immunometabolism in systemic lupus erythematosus.
    Psarras A; Clarke A
    Oxf Open Immunol; 2023; 4(1):iqad005. PubMed ID: 37554724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Immunometabolism in the Pathogenesis of Systemic Lupus Erythematosus.
    Robinson GA; Wilkinson MGL; Wincup C
    Front Immunol; 2021; 12():806560. PubMed ID: 35154082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting abnormal lipid metabolism of T cells for systemic lupus erythematosus treatment.
    Hu JQ; Yan YH; Xie H; Feng XB; Ge WH; Zhou H; Yu LL; Sun LY; Xie Y
    Biomed Pharmacother; 2023 Sep; 165():115198. PubMed ID: 37536033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism as a key regulator in the pathogenesis of systemic lupus erythematosus.
    Takeshima Y; Iwasaki Y; Fujio K; Yamamoto K
    Semin Arthritis Rheum; 2019 Jun; 48(6):1142-1145. PubMed ID: 31056210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic perspectives on the metabolism of lymphocytes in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Iwata S; Tanaka Y
    Expert Rev Clin Immunol; 2021 Oct; 17(10):1121-1130. PubMed ID: 34351835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Factors that Contribute to Lupus Pathogenesis.
    Li W; Sivakumar R; Titov AA; Choi SC; Morel L
    Crit Rev Immunol; 2016; 36(1):75-98. PubMed ID: 27480903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the Protective Arm of the Renin-Angiotensin System to Reduce Systemic Lupus Erythematosus Related Pathologies in MRL
    Soto M; Delatorre N; Hurst C; Rodgers KE
    Front Immunol; 2020; 11():1572. PubMed ID: 32793221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological mechanisms of abnormal iron metabolism and mitochondrial dysfunction in systemic lupus erythematosus.
    Wincup C; Sawford N; Rahman A
    Expert Rev Clin Immunol; 2021 Sep; 17(9):957-967. PubMed ID: 34263712
    [No Abstract]   [Full Text] [Related]  

  • 15. The Role of Mitochondria in Systemic Lupus Erythematosus: A Glimpse of Various Pathogenetic Mechanisms.
    Yang SK; Zhang HR; Shi SP; Zhu YQ; Song N; Dai Q; Zhang W; Gui M; Zhang H
    Curr Med Chem; 2020; 27(20):3346-3361. PubMed ID: 30479205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunometabolism in the pathogenesis of systemic lupus erythematosus.
    Zhang CX; Wang HY; Yin L; Mao YY; Zhou W
    J Transl Autoimmun; 2020; 3():100046. PubMed ID: 32743527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota in Human Systemic Lupus Erythematosus and a Mouse Model of Lupus.
    Luo XM; Edwards MR; Mu Q; Yu Y; Vieson MD; Reilly CM; Ahmed SA; Bankole AA
    Appl Environ Microbiol; 2018 Feb; 84(4):. PubMed ID: 29196292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic determinants of lupus pathogenesis.
    Teng X; Brown J; Choi SC; Li W; Morel L
    Immunol Rev; 2020 May; 295(1):167-186. PubMed ID: 32162304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA.
    Becker Y; Marcoux G; Allaeys I; Julien AS; Loignon RC; Benk-Fortin H; Rollet-Labelle E; Rauch J; Fortin PR; Boilard E
    Front Immunol; 2019; 10():1026. PubMed ID: 31134086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial impairment and repair in the pathogenesis of systemic lupus erythematosus.
    Zhao L; Hu X; Xiao F; Zhang X; Zhao L; Wang M
    Front Immunol; 2022; 13():929520. PubMed ID: 35958572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.